Advertisement
Organisation › Details
Absci Corporation (Nasdaq: ABSI)
AbSci is a leading synthetic biology company focused on redefining protein biomanufacturing. We are making protein production as simple as DNA synthesis through our revolutionary Protein Printing™ technology. AbSci enables a pathway to commercialization for biologics that otherwise wouldn’t get to market due to poor manufacturability. Our mission is to improve patients’ lives by reducing drug costs, accelerating development timelines, and enabling new biologic therapies to market. *
Start | 2011-01-01 established (s-off) | |
Predecessor | AbSci LLC | |
Industry | synthetic biotechnology | |
City | n. a. | |
Address record changed: 2023-11-16 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: AbSci, LLC. (10/20/20). "Press Release: AbSci Announces $65 Million Financing Led by Casdin Capital". Vancouver, WA. | ||
Record changed: 2023-11-16 |
Advertisement
More documents for Absci Corporation (Nasdaq: ABSI)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top